X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE NOVARTIS SUVEN LIFE/
NOVARTIS
 
P/E (TTM) x 19.3 361.7 5.3% View Chart
P/BV x 3.6 17.8 20.1% View Chart
Dividend Yield % 1.0 1.6 64.5%  

Financials

 SUVEN LIFE   NOVARTIS
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
NOVARTIS
Mar-16
SUVEN LIFE/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs339982 34.5%   
Low Rs144556 26.0%   
Sales per share (Unadj.) Rs39.2252.9 15.5%  
Earnings per share (Unadj.) Rs7.562.1 12.0%  
Cash flow per share (Unadj.) Rs8.863.3 13.9%  
Dividends per share (Unadj.) Rs2.0010.00 20.0%  
Dividend yield (eoy) %0.81.3 63.7%  
Book value per share (Unadj.) Rs49.0363.6 13.5%  
Shares outstanding (eoy) m127.2831.96 398.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.23.0 202.3%   
Avg P/E ratio x32.412.4 261.5%  
P/CF ratio (eoy) x27.512.2 226.4%  
Price / Book Value ratio x4.92.1 233.0%  
Dividend payout %26.816.1 166.6%   
Avg Mkt Cap Rs m30,73224,580 125.0%   
No. of employees `0001.00.8 126.9%   
Total wages/salary Rs m4161,801 23.1%   
Avg. sales/employee Rs Th5,236.110,748.9 48.7%   
Avg. wages/employee Rs Th436.52,395.2 18.2%   
Avg. net profit/employee Rs Th995.52,641.1 37.7%   
INCOME DATA
Net Sales Rs m4,9958,083 61.8%  
Other income Rs m194829 23.3%   
Total revenues Rs m5,1898,913 58.2%   
Gross profit Rs m1,233234 526.3%  
Depreciation Rs m16737 455.6%   
Interest Rs m542 3,011.1%   
Profit before tax Rs m1,2051,025 117.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m017 0.0%   
Extraordinary Inc (Exp) Rs m01,696 0.0%   
Tax Rs m255752 33.9%   
Profit after tax Rs m9501,986 47.8%  
Gross profit margin %24.72.9 851.7%  
Effective tax rate %21.273.4 28.9%   
Net profit margin %19.024.6 77.4%  
BALANCE SHEET DATA
Current assets Rs m4,98612,678 39.3%   
Current liabilities Rs m1,0422,433 42.8%   
Net working cap to sales %79.0126.7 62.3%  
Current ratio x4.85.2 91.8%  
Inventory Days Days6133 186.5%  
Debtors Days Days3922 174.0%  
Net fixed assets Rs m3,12669 4,516.6%   
Share capital Rs m127160 79.7%   
"Free" reserves Rs m3,71711,460 32.4%   
Net worth Rs m6,23611,621 53.7%   
Long term debt Rs m4320-   
Total assets Rs m8,07914,400 56.1%  
Interest coverage x23.2570.5 4.1%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.60.6 110.1%   
Return on assets %12.413.8 90.0%  
Return on equity %15.217.1 89.1%  
Return on capital %18.923.6 80.1%  
Exports to sales %87.50.7 11,748.0%   
Imports to sales %12.218.6 65.8%   
Exports (fob) Rs m4,37160 7,260.0%   
Imports (cif) Rs m6111,503 40.6%   
Fx inflow Rs m4,666186 2,504.8%   
Fx outflow Rs m9421,821 51.7%   
Net fx Rs m3,724-1,635 -227.9%   
CASH FLOW
From Operations Rs m9222,531 36.4%  
From Investments Rs m-619-8,270 7.5%  
From Financial Activity Rs m-698-386 181.1%  
Net Cashflow Rs m-396-6,125 6.5%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 2.0 -  
FIIs % 0.0 1.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 21.5 169.8%  
Shareholders   37,287 41,647 89.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   MERCK LTD  VENUS REMEDIES  IPCA LABS  WOCKHARDT LTD.  AUROBINDO PHARMA  

Compare SUVEN LIFE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Metal Stocks Top Losers(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading marginally above the dotted line.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Feb 21, 2018 02:57 PM

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS